Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tigertriever and Tigertriever 17 Revascularization Devce

K-Number: K203592 · 2021-03-23

Decision Date2021-03-23
Product CodeNRY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Tigertriever and Tigertriever 17 Revascularization Devce is a medical device manufactured by Rapid Medical , Ltd.. It received FDA 510(k) clearance on 2021-03-23 under approval number K203592. The device is classified under product code NRY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tigertriever and Tigertriever 17 Revascularization Devce?

Tigertriever and Tigertriever 17 Revascularization Devce is a medical device that received FDA 510(k) clearance on 2021-03-23. It is manufactured by Rapid Medical , Ltd.. The 510(k) number is K203592.

When was Tigertriever and Tigertriever 17 Revascularization Devce approved by the FDA?

Tigertriever and Tigertriever 17 Revascularization Devce received FDA 510(k) clearance on 2021-03-23, under approval number K203592.

What company makes Tigertriever and Tigertriever 17 Revascularization Devce?

Tigertriever and Tigertriever 17 Revascularization Devce is manufactured by Rapid Medical , Ltd..

What is the FDA product code for Tigertriever and Tigertriever 17 Revascularization Devce?

The FDA product code for Tigertriever and Tigertriever 17 Revascularization Devce is NRY.

Other Devices by Rapid Medical , Ltd.

Related Devices (Code: NRY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.